×
About 2,438 results

ALLMedicine™ Atrioventricular Block Center

Research & Reviews  887 results

Symptomatic atrial bigeminy masquerading as congenital complete heart block.
https://doi.org/10.1017/S104795112100384X
Cardiology in the Young; Mejia E, Hoyt WJ et. al.

Sep 22nd, 2021 - Newborn male with symptomatic bradycardia initially diagnosed with complete atrioventricular block. Isoproterenol drip was initiated, and the patient was scheduled for pacemaker implantation. During the hospital course, repeat electrocardiogram an...

Time Course and Risk Factors of New-Onset Complete Atrioventricular Block After Transca...
https://doi.org/10.1536/ihj.20-824
International Heart Journal; Cha MJ, Oh GC et. al.

Sep 22nd, 2021 - In this study, we aimed to investigate the time course of new-onset complete atrioventricular block (CAVB) and its reversibility after transcatheter aortic valve implantation (TAVI). We analyzed 206 consecutive patients without baseline CAVB who u...

Bedside Electrophysiological Study Using a Temporary Pacemaker May Predict Recurrence o...
https://doi.org/10.1536/ihj.21-145
International Heart Journal; Nauchi M, Yamawaki M et. al.

Sep 22nd, 2021 - High-degree atrioventricular block (HAVB) or complete heart block (CHB) is a common complication associated with transcatheter aortic valve replacement (TAVR). However, some patients with HAVB/CHB recover with time. The results of electrophysiolog...

Management of heart failure with concomitant complete atrioventricular block caused by ...
https://doi.org/10.1016/j.jelectrocard.2021.09.004
Journal of Electrocardiology; Hayıroğlu Mİ, Şekerci SS et. al.

Sep 19th, 2021 - A 30-year-old lady was admitted to the hospital with progressive exertional dyspnoea and bradycardia. A complete atrioventricular block was diagnosed using 12‑lead electrocardiography and a transthoracic echocardiography revealed a severely impair...

Permanent His-bundle pacing using distal His-bundle electrogram-guided approach in pati...
https://doi.org/10.1111/pace.14363
Pacing and Clinical Electrophysiology : PACE; Suga K, Kato H et. al.

Sep 15th, 2021 - Permanent His-bundle pacing (HBP) is effective and safe; however, the success rate of HBP is low, especially in patients with infranodal block. This study aimed to assess the efficacy and feasibility of HBP implantation using an electrophysiologic...

see more →

Drugs  34 results see all →

News  54 results

Atrioventricular Block Common in Children With Multisystem Inflammatory Syndrome
https://www.medscape.com/viewarticle/940084

Nov 2nd, 2020 - NEW YORK (Reuters Health) - Atrioventricular block (AVB) occurs in about one of five children with multisystem inflammatory syndrome (MIS-C) following SARS-CoV-2 infection, according to a new study. Initial reports from Europe on the features of M...

Atrioventricular Block Common in Children With Multisystem Inflammatory Syndrome
https://www.staging.medscape.com/viewarticle/940084

Nov 2nd, 2020 - NEW YORK (Reuters Health) - Atrioventricular block (AVB) occurs in about one of five children with multisystem inflammatory syndrome (MIS-C) following SARS-CoV-2 infection, according to a new study. Initial reports from Europe on the features of M...

ECG Challenge: Tennis Player With an Irregular Pulse
https://www.medscape.com/viewarticle/930293_2

May 18th, 2020 - What does his ECG show? Your Peers Chose: Sinus arrhythmia 0% Normal sinus rhythm and sinus pauses 0% Normal sinus rhythm and nonconducted premature atrial complexes 0% Normal sinus rhythm and second-degree atrioventricular block 0% Atrial tachyca...

An Unusual Presentation of Calciphylaxis
https://www.mdedge.com/dermatology/article/219998/rare-diseases/unusual-presentation-calciphylaxis/page/0/1?channel=44

Apr 1st, 2020 - The pathogenesis of calciphylaxis is not well understood; however, some researchers suggest that an imbalance in calcium-phosphate homeostasis may lead to calciphylaxis; that is, elevated calcium and phosphate levels exceed their solubility and de.

Relapsing MS: Ozanimod Tops Fingolimod in Benefit-Risk Profile
https://www.mdedge.com/neurology/msresourcecenter/article/217365/multiple-sclerosis/relapsing-ms-ozanimod-tops-fingolimod?channel=251

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

see more →